blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1410022

EP1410022 - DETECTION AND TREATMENT OF PROSTATE CANCER [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.03.2010
Database last updated on 30.09.2024
Most recent event   Tooltip07.10.2011Lapse of the patent in a contracting state
New state(s): CY, TR		published on 09.11.2011  [2011/45]
Applicant(s)For all designated states
GlycoMimetics, Inc.
101 Orchard Ridge Drive, Suite 1E
Gaithersburg, MD 20878 / US
[2009/18]
Former [2004/17]For all designated states
Glycomimetics, Inc.
14915 Broschart Road, Suite 200
Rockville, MD 20850 / US
Inventor(s)01 / MAGNANI, John L.
12216 Triple Crown Road
Gaithersburg, MD 20878 / US
 [2009/17]
Former [2004/17]01 / MAGNANI, John L.
325 West Side Drive, Apartment 101
Gaithersburg, MD 20878 / US
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstrasse 4
80802 München / DE
[N/P]
Former [2004/17]Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
Maximilianstrasse 58
80538 München / DE
Application number, filing date02742263.321.06.2002
[2004/17]
WO2002US19851
Priority number, dateUS20010300250P21.06.2001         Original published format: US 300250 P
[2004/17]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03000117
Date:03.01.2003
Language:EN
[2003/01]
Type: A2 Application without search report 
No.:EP1410022
Date:21.04.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 03.01.2003 takes the place of the publication of the European patent application.
[2004/17]
Type: B1 Patent specification 
No.:EP1410022
Date:06.05.2009
Language:EN
[2009/19]
Search report(s)International search report - published on:US13.11.2003
(Supplementary) European search report - dispatched on:EP30.06.2005
ClassificationIPC:G01N33/574, A61K49/00
[2008/48]
CPC:
C07K16/3069 (EP,US); A61P35/00 (EP); G01N33/57434 (EP,US);
G01N2405/10 (EP,US)
Former IPC [2004/17]G01N33/53, C07H7/02
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/17]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:NACHWEIS UND BEHANDLUNG VON PROSTATAKREBS[2004/17]
English:DETECTION AND TREATMENT OF PROSTATE CANCER[2004/17]
French:DETECTION ET TRAITEMENT DU CANCER DE LA PROSTATE[2004/17]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase21.01.2004National basic fee paid 
21.01.2004Search fee paid 
21.01.2004Designation fee(s) paid 
21.01.2004Examination fee paid 
Examination procedure14.01.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
21.01.2004Amendment by applicant (claims and/or description)
21.01.2004Examination requested  [2004/17]
08.03.2006Despatch of a communication from the examining division (Time limit: M06)
15.09.2006Reply to a communication from the examining division
22.06.2007Despatch of a communication from the examining division (Time limit: M04)
15.10.2007Reply to a communication from the examining division
07.10.2008Date of oral proceedings
10.10.2008Cancellation of oral proceeding that was planned for 15.10.2008
10.10.2008Minutes of oral proceedings despatched
15.10.2008Date of oral proceedings
15.10.2008Date of oral proceedings (cancelled)
10.11.2008Communication of intention to grant the patent
18.03.2009Fee for grant paid
18.03.2009Fee for publishing/printing paid
Opposition(s)09.02.2010No opposition filed within time limit [2010/15]
Fees paidRenewal fee
23.06.2004Renewal fee patent year 03
21.06.2005Renewal fee patent year 04
28.06.2006Renewal fee patent year 05
27.06.2007Renewal fee patent year 06
25.06.2008Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT06.05.2009
BE06.05.2009
CY06.05.2009
DK06.05.2009
FI06.05.2009
IT06.05.2009
NL06.05.2009
TR06.05.2009
IE21.06.2009
LU21.06.2009
CH30.06.2009
LI30.06.2009
MC30.06.2009
SE06.08.2009
GR07.08.2009
ES17.08.2009
PT06.09.2009
[2011/44]
Former [2011/21]AT06.05.2009
BE06.05.2009
DK06.05.2009
FI06.05.2009
IT06.05.2009
NL06.05.2009
IE21.06.2009
LU21.06.2009
CH30.06.2009
LI30.06.2009
MC30.06.2009
SE06.08.2009
GR07.08.2009
ES17.08.2009
PT06.09.2009
Former [2011/14]AT06.05.2009
BE06.05.2009
DK06.05.2009
FI06.05.2009
IT06.05.2009
NL06.05.2009
IE21.06.2009
CH30.06.2009
LI30.06.2009
MC30.06.2009
SE06.08.2009
GR07.08.2009
ES17.08.2009
PT06.09.2009
Former [2010/48]AT06.05.2009
BE06.05.2009
DK06.05.2009
FI06.05.2009
NL06.05.2009
IE21.06.2009
CH30.06.2009
LI30.06.2009
MC30.06.2009
SE06.08.2009
GR07.08.2009
ES17.08.2009
PT06.09.2009
Former [2010/21]AT06.05.2009
BE06.05.2009
DK06.05.2009
FI06.05.2009
NL06.05.2009
IE21.06.2009
CH30.06.2009
LI30.06.2009
MC30.06.2009
SE06.08.2009
ES17.08.2009
PT06.09.2009
Former [2010/10]AT06.05.2009
BE06.05.2009
DK06.05.2009
FI06.05.2009
NL06.05.2009
MC30.06.2009
SE06.08.2009
ES17.08.2009
PT06.09.2009
Former [2010/08]AT06.05.2009
DK06.05.2009
FI06.05.2009
NL06.05.2009
MC30.06.2009
SE06.08.2009
ES17.08.2009
PT06.09.2009
Former [2010/07]AT06.05.2009
FI06.05.2009
NL06.05.2009
MC30.06.2009
SE06.08.2009
ES17.08.2009
PT06.09.2009
Former [2009/52]AT06.05.2009
FI06.05.2009
NL06.05.2009
SE06.08.2009
ES17.08.2009
PT06.09.2009
Former [2009/50]AT06.05.2009
FI06.05.2009
NL06.05.2009
ES17.08.2009
PT06.09.2009
Former [2009/49]AT06.05.2009
FI06.05.2009
ES17.08.2009
PT06.09.2009
Former [2009/46]ES17.08.2009
Documents cited:Search[X]WO9703701  (GLYCOTECH CORP [US], et al) [X] 6,8,9,12 * page 8, line 21; claims 12-22 * * page 13, lines 3-5 *;
 [A]  - NUDELMAN E D ET AL, "A series of disialogangliosides with binary 2-3 sialosyllactosamine structure, defined by monoclonal antibody NUH2, are oncodevelopmentally regulated antigens", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, (19891105), vol. 264, no. 31, ISSN 0021-9258, pages 18719 - 18725, XP002961833 [A] 1-15,18 * the whole document *
 [A]  - SHIRAISHI T ET AL, "THE GLYCOSPHINGOLIPIDS OF HUMAN PROSTATE TISSUE", BBA - LIPIDS AND LIPID METABOLISM, ELSEVIER SCIENCE BV. AMSTERDAM, NL, (1988), vol. 961, no. 2, ISSN 0005-2760, pages 160 - 169, XP008048167 [A] 1-15,18 * table I *

DOI:   http://dx.doi.org/10.1016/0005-2760(88)90109-9
 [A]  - SATOH M ET AL, "GLYCOLIPID EXPRESSION IN PROSTATIC TISSUE AND ANALYSIS OF THE ANTIGEN RECOGNIZED BY ANTIPROSTATIC MONOCLONAL ANTIBODY APG1", UROLOGIA INTERNATIONALIS, KARGER, BASEL, CH, (1992), vol. 48, no. 1, ISSN 0042-1138, pages 20 - 24, XP008048162 [A] 1-15,18 * page 23, column 2, paragraph 1 *
 [A]  - LAGANA ALDO ET AL, "Determination of serum total lipid and free N-acetylneuraminic acid in genitourinary malignancies by fluorimetric high performance liquid chromatography: Relevance of free N-acetylneuraminic acid as tumour marker", CLINICA CHIMICA ACTA, (1995), vol. 243, no. 2, ISSN 0009-8981, pages 165 - 179, XP002331568 [A] 1-15,18 * page 174, paragraphs 5,6; figure 1C; tables 1,2 * * page 176, paragraphs 6,7 *

DOI:   http://dx.doi.org/10.1016/0009-8981(95)06165-7
International search[X]  - ITAI ET AL., "Differentiation-dependent expression of I and sialyl I antigens in the developing lung of human embryos and in lung cancers", CANCER RESEARCH, (19901201), vol. 50, no. 23, pages 7603 - 7611, XP002961832
 [A]  - NUDELMAN ET AL., "A series of disialogangliosides with binary 2-3 sialosyllactosamine structure, defined by monoclonal antibody NUH2, are oncodevelopmentally regulated antigens", J. BIOL. CHEM., (19891105), vol. 264, no. 31, pages 18719 - 18725, XP002961833
 [A]  - KANNAGI ET AL., "Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl type 2 chain polylactosamine", CANCER RES., (1986), vol. 46, pages 2619 - 2626, XP002961836
ExaminationUS5227160
    - TAILOR-PAPADIMITRIOU, "Report on the first international workshop on carcinoma associated mucins", INT J CANCER, (1991), vol. 49, pages 1 - 5
    - BALLANGRUD, "Response of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591).", CANCER RESEARCH, (2001), vol. 61, pages 2008 - 2014
    - SAFFRAN, "Target antigens for prostate cancer immunotherapy.", CANC METASTASIS REV, (1999), vol. 18, pages 437 - 449
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.